<DOC>
	<DOCNO>NCT01465152</DOCNO>
	<brief_summary>This trial conduct Europe . The aim trial compare efficacy metformin repaglinide use alone combine administered initial treatment subject type 2 diabetes diet exercise fail .</brief_summary>
	<brief_title>Comparison Metformin , Repaglinide Combination Both Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Repaglinide</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Subjects type 2 diabetes Treated diet least 3 month Never treat hypoglycaemic drug HbA1c ( glycaemic haemoglobin A1c ) inclusion time superior 6.5 % Very symptomatic diabetes Advanced vascular complication Manifest renal failure Manifest hepatic disease Pregnancy , breast feeding intention become pregnant consider patient use adequate contraceptive measure . Adequate contraceptive measure consider intrauterine device , oral contraceptive barrier method</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>February 2017</verification_date>
</DOC>